Clinical Trial Information
An Open-label Extension Study of Inhaled Treprostinil in Subjects with
Idiopathic Pulmonary Fibrosis
- Protocol Number: 14966
- Status: Open
- Treatment Type: Treatment
- Secondary Protocol No.: RIN-PF-302
- Phase: III
- NCT ID: NCT04905693
Scope Information
- Scope:
- National
- Disease Site(s):
- Other
